时间标签：数据日期 2026-11-05 · 生成时间 2026-11-05 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/11/02 – 2026/11/06 ｜ 情报发生日期 2026-11-05
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
摘要（PubMed 原文节选）
BACKGROUND: In older patients (≥65 years), the evidence for continued statin prescription is scarce. Although statins are commonly discontinued in the context of advancing age or frailty, there is little evidence to guide decision making. Hence, we aimed to investigate the risks and benefits of statin discontinuation in older people, stra…
对本项目的价值
参考价值：属「衰弱 / 肌少症功能结局」方向；肌肉骨骼 / 衰弱 / 肌少症栏目可用作本项目文献库与综述素材。 ｜ 价值分 1.5/5（★★☆☆☆）
全文不可及原因
无 PMCID 且 Europe PMC / OpenAlex / Unpaywall 未提供可下载 OA 全文
原文题录
- 中文题名：65 岁及以上患者按衰弱状态评估停用他汀的疗效与安全性：基于 CPRD 数据的英格兰全人群回顾性队列研究
- 英文标题：Efficacy and safety of statin discontinuation in patients 65 years and older according to frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data.
- 期刊与标识：The lancet. Healthy longevity · PMID 42971235 · DOI 10.1016/j.lanhl.2026.100920